Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing. This review looks at the value of pre-treatment anti-Mullerian hormone (AMH) value in choosing the appropriate modality of treatment and its predictive ability for the outcomes of such treatment. It briefly addresses the factors that may modulate AMH levels and make clinical decision-making challenging.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11041323 | PMC |
| http://dx.doi.org/10.4103/jhrs.jhrs_153_23 | DOI Listing |
Publication Analysis
Top Keywords
anti-mullerian hormone
12
choosing appropriate
8
hormone fertility
4
fertility treatment
4
treatment decisions
4
decisions polycystic
4
polycystic ovary
4
ovary syndrome
4
syndrome literature
4
literature review
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!